Wed, November 14, 2018
Tue, November 13, 2018
Mon, November 12, 2018
Fri, November 9, 2018

Liav Abraham Maintained (ABEO) at Strong Buy with Decreased Target to $700 on, Nov 13th, 2018

Liav Abraham of Citigroup, Maintained "Abeona Therapeutics Inc." (ABEO) at Strong Buy with Decreased Target from $800 to $700 on, Nov 13th, 2018.

Liav, nor any peers, have made any analyst calls on ABEO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30